GROWTH EQUITY OPPORTUNITIES FUND III, LLC / AURINIA PHARMACEUTICALS INC.

Company

Aurinia Pharmaceuticals Inc.

Filed

January 9, 2017

Accession Number

0001072613-17-000009

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →